2015
Novel Oral Anticoagulants: Efficacy, Laboratory Measurement, and Approaches to Emergent Reversal
Gehrie E, Tormey C. Novel Oral Anticoagulants: Efficacy, Laboratory Measurement, and Approaches to Emergent Reversal. Archives Of Pathology & Laboratory Medicine 2015, 139: 687-92. PMID: 25927153, DOI: 10.5858/arpa.2013-0677-rs.Peer-Reviewed Original ResearchConceptsNovel oral anticoagulantsManagement of NOACOral direct thrombin inhibitorDirect factor Xa inhibitorVitamin K antagonistsDirect thrombin inhibitorFactor Xa inhibitorsCertain clinical circumstancesOral anticoagulationWarfarin effectivenessK antagonistsOral anticoagulantsClinical efficacySafety profileEmergent reversalClinical circumstancesXa inhibitorsUS FoodDrug AdministrationThrombin inhibitorsNew drugsDrugsEfficacyInhibitorsLaboratory assays
2010
Evidence‐based practice guidelines for plasma transfusion
Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, Fung M, Hamilton M, Hess JR, Luban N, Perkins JG, Sachais BS, Shander A, Silverman T, Snyder E, Tormey C, Waters J, Djulbegovic B. Evidence‐based practice guidelines for plasma transfusion. Transfusion 2010, 50: 1227-1239. PMID: 20345562, DOI: 10.1111/j.1537-2995.2010.02632.x.Peer-Reviewed Original ResearchConceptsTransfusion of plasmaPlasma transfusionCommon clinical scenariosMassive transfusionEvidence-based guidanceSystematic reviewIntracranial hemorrhageTransfusion decisionsPractice guidelinesClinical scenariosRed blood cell ratioEvidence-based practice guidelinesMultidisciplinary guideline panelPlasma transfusion guidelinesBlood cell ratioGroup of patientsClinical practice guidelinesAppropriate transfusionTransfusion guidelinesWarfarin anticoagulationGRADE methodologyGuideline panelObservational studyTransfusionDefinitive guidelines